Aura Biosciences to Participate in the JMP Securities Life S

Aura Biosciences Inc. , a clinical-stage biotechnology company developing a novel class of virus-like drug conjugate therapies for multiple oncology indications, today announced that Elisabet de los... | May 12, 2023

Related Keywords

Boston , Massachusetts , United States , Los Pinos , Securities Life Sciences Conference On , Twitter , Nasdaq , Aura Biosciences Inc , Linkedin , Aura Biosciences , Elisabet De Los Pinos , Chief Executive Officer , Life Sciences Conference , Nc Stock Exchange , News , Information , Press Release , Laura , Iosciences , Biotechnology , Company , Developing , Novel , Glass , F , Drug , Conjugate , Therapies , Or , Multiple , Ncology , Oday , Nnounced , Hat , Lisabet Aura Us05153u1079 ,